Syndax Pharmaceuticals (SNDX) Assets Growth (1y) (2016 - 2026)
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.29 Bn | 60.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.03% |
| Mar 31, 2026 | -26.23% |
| Dec 31, 2025 | -26.92% |
| Sep 30, 2025 | 29.59% |
| Jun 30, 2025 | 24.99% |
| Mar 31, 2025 | 17.99% |
| Dec 31, 2024 | 18.26% |
| Sep 30, 2024 | 6.66% |
| Jun 30, 2024 | 10.57% |
| Mar 31, 2024 | 18.09% |
| Dec 31, 2023 | 23.26% |
| Sep 30, 2023 | 10.99% |
| Jun 30, 2023 | 6.13% |
| Mar 31, 2023 | 8.91% |
| Dec 31, 2022 | 10.58% |
| Sep 30, 2022 | 50.18% |
| Jun 30, 2022 | 54.50% |
| Mar 31, 2022 | 50.97% |
| Dec 31, 2021 | 49.58% |
| Sep 30, 2021 | 33.57% |